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An integrated network representation of multiple cancerspeciﬁc data for graph-based machine learning

1234567890():,;

Limeng Pu1,6, Manali Singha2,6, Hsiao-Chun Wu3, Costas Busch4,5, J. Ramanujam1,3 and Michal Brylinski

1,2 ✉

Genomic proﬁles of cancer cells provide valuable information on genetic alterations in cancer. Several recent studies employed
these data to predict the response of cancer cell lines to drug treatment. Nonetheless, due to the multifactorial phenotypes and
intricate mechanisms of cancer, the accurate prediction of the effect of pharmacotherapy on a speciﬁc cell line based on the
genetic information alone is problematic. Emphasizing on the system-level complexity of cancer, we devised a procedure to
integrate multiple heterogeneous data, including biological networks, genomics, inhibitor proﬁling, and gene-disease associations,
into a uniﬁed graph structure. In order to construct compact, yet information-rich cancer-speciﬁc networks, we developed a novel
graph reduction algorithm. Driven by not only the topological information, but also the biological knowledge, the graph reduction
increases the feature-only entropy while preserving the valuable graph-feature information. Subsequent comparative
benchmarking simulations employing a tissue level cross-validation protocol demonstrate that the accuracy of a graph-based
predictor of the drug efﬁcacy is 0.68, which is notably higher than those measured for more traditional, matrix-based techniques on
the same data. Overall, the non-Euclidean representation of the cancer-speciﬁc data improves the performance of machine learning
to predict the response of cancer to pharmacotherapy. The generated data are freely available to the academic community at
https://osf.io/dzx7b/.
npj Systems Biology and Applications (2022)8:14 ; https://doi.org/10.1038/s41540-022-00226-9

INTRODUCTION
Carcinogenesis is a systems-level phenomenon with a complex
phenotype concomitant with the malfunction of signal transduction in a cell1–3. Biological networks, including protein-protein
interaction (PPI) networks, are often employed to study the
alteration of information ﬂow in cancer cells caused by oncogenic
changes in protein activity and expression4–6. Many early networkbased methods build on the observation that gene products
associated with similar diseases exhibit similar topological
characteristics of PPI networks. For instance, Vavien utilizes the
information ﬂow in networks to extract functional disease-gene
relationships in order to identify target genes for pharmacotherapy7. Systematic benchmarks of Vavien against the Online
Mendelian Inheritance in Man database demonstrated that
disease-gene candidates can effectively be prioritized based on
their topological similarity to known disease-associated genes. A
more recent study comprehensively analyzed 150 anticancer
drugs approved by the US Food and Drug Administration divided
into two groups according to their mechanism of action, cytotoxic
and target-based agents8. It was found that although the
proportion of target-based drugs increased in recent years,
cytotoxic agents are used to treat more cancer types. Further,
the investigation of the cancer-drug-target network comprising
multiple cancer types, drugs, and targets revealed novel drugcancer associations, most of which are supported by at least one
clinical trial study.
These studies exemplify the utility of biological networks to
address challenging tasks in cancer research, such as the efﬁcacy
prediction for anticancer drugs. Not surprisingly, there is a
signiﬁcant interest in the development of machine-learning

systems applicable to graph-structured data9 in order to further
improve the information extraction and induction from biological
networks. Graph-based machine-learning approaches can broadly
be categorized into two major classes, graph kernels and spectral
methods. An exemplar of the former technique is the
Weisfeiler–Lehman (WL) algorithm10, which iteratively assigns a
label to each node based on the multi-set hashing of the neighbor
labels. Subsequently, graph-level features are computed from
either a histogram or another form of summarizing statistics for
individual nodes. On the other hand, spectral methods utilize the
graph Laplacian, a matrix calculated from the adjacency matrix of
a graph11. A variety of matrix-related operations, such as
eigenvalue decomposition, can be applied to the Laplacian to
cluster nodes into different groups and perform graph classiﬁcation. Alternative techniques to classify nodes and compute various
graph statistics include PageRank, a random walk-based algorithm
proposed by the founders of Google12. This technique determines
the importance of a page, represented as a node in the graph, by
counting the number and quality of links under the assumption
that more important websites receive more links from other
websites.
Recently developed graph-based machine-learning approaches
for applications in biology and biomedicine include a new
prediction method combining multiple kernels into a tripartite,
heterogeneous drug-target-disease interaction space in order to
integrate multiple sources of biological information13. This novel
network-based algorithm adds a disease layer to the traditional
drug-target interaction bipartite graph. From the constructed
heterogeneous network, new drug-target interactions can be
inferred with Gaussian kernel functions and the regularized least
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square method of the Kronecker product. Encouragingly, comprehensive benchmarking simulations demonstrated that the
network topology can be used to accurately detect drug-target
interactions. Another example is a machine-learning framework to
identify robust drug biomarkers with network-based analyses of
the pharmacogenomic data derived from three-dimensional
organoid culture models14. These biomarkers were shown to
reliably predict responses of colorectal cancer patients to
5-ﬂuorouracil and bladder cancer patients to cisplatin. Finally,
biomarkers were conﬁrmed against the external transcriptomic
datasets of drug-sensitive and drug-resistant isogenic cancer cell
lines, demonstrating that combining the application of gene
modules and network-based techniques can be used to predict
anticancer-drug efﬁcacy in patients.
A major challenge for the application of machine-learning
systems to biological networks is to ensure that these data contain
a sufﬁciently high signal-to-noise ratio for the learning framework
to efﬁciently perform information extraction and high-level
induction. In addition, the size of many biological networks, such
as PPI networks comprising thousands of nodes, is prohibitively
large for many algorithms and, therefore, should preferably be
reduced to facilitate a fast-learning process. To address these
challenges, we describe a novel procedure to construct compact
yet information-rich, cancer-speciﬁc graphs by integrating multiple heterogeneous data on differential gene expression, drug
proﬁling, protein-protein interactions, and disease association
scores. The resulting networks are characterized by various graphbased statistics and their information content is evaluated with
topological and feature entropy measures. Finally, we conduct a
comparative analysis of the performance of matrix- and graphbased predictors of the drug efﬁcacy employing a tissue level
cross-validation protocol. Overall, the integrated network representation of heterogeneous biological data improves the performance of machine learning to predict the effect of a drug
treatment on the cancer cell growth over more traditional matrixbased approaches.
RESULTS
Construction of cancer-speciﬁc networks
Integration of the heterogeneous, cancer-speciﬁc data was
performed by mapping the differential gene expression, diseasegene association scores, and kinase inhibitor proﬁling onto the
human PPI network. The PPI network contains the majority of
proteins and connections of the human phosphorylation network,
yet it is larger, more diverse and strongly connected15. The
integration procedure is schematically shown in Fig. 1. An initial
network has two types of nodes representing kinases (circles) and
non-kinase proteins (rounded squares). For a given cell line, up(green) and down-regulated (red) genes are marked according to
the differential gene expression for that cell line and some nodes
are also assigned disease-gene association scores (numbers in
bold). If this cell line is treated with a kinase inhibitor, pIC50 values
against its targets are then added to the graph (numbers in italics).
In the resulting graph, kinase nodes have gene expression values,
and some kinase nodes also have pIC50 values and disease-gene
association scores. Non-kinase nodes have gene expression
values, and some non-kinases nodes also have disease-gene
association scores. Note that all cell line-drug combinations have
the same underlying PPI network, however, different cell lines
usually have different gene expression values and disease
association scores that depend on the tumor type. Similarly,
various drugs usually inhibit different sets of kinases, therefore,
node features are generally unique for cell line-drug
combinations.
npj Systems Biology and Applications (2022) 14

Fig. 1 Schematic of the graph representation of multiple
heterogeneous data. Circles are kinases, whereas rounded squares
represent non-kinase proteins. Nodes are connected through
conﬁdent interactions forming a network. Each node is colored
according to the differential gene expression: green—up-regulated,
red —down-regulated, and gray—normally regulated. Both types of
nodes can have gene-disease association scores (numbers in bold),
whereas kinases can also have pIC50 values according to the kinase
proﬁling data (numbers in italics).

Analysis of full-size networks
In the context of machine learning, full-size graphs corresponding
to the original PPI networks are not necessarily the best
representation of the cancer-speciﬁc data. First, all instances share
the same graph topology and differences are only in node
features, i.e., gene expression, disease association, and pIC50
values, making it difﬁcult for a machine-learning model to gather
the information required for effective learning. Second, full-size
graphs are very sparse with a density (see Eq. 1) as low as 0.004
wasting the computer memory. A quick ﬁx to this problem could
be to employ a sparse representation, such as the coordination
(COO) format16, however, this approach is unworkable because
available machine-learning libraries do not support sparse data
formats. Third, the majority (98%) of nodes in a graph are nonkinase proteins with no inhibition data and most proteins are
normally regulated according to the differential gene expression
leading to a signiﬁcant sparsity of important features. As a result,
most entries in the feature matrix carry no effective information,
which may result in a poor learning performance. An illustrative
analogy is to try training a model to classify images having less
than 1% different pixels. Given such tiny differences, any model is
going to struggle learning the underlying patterns.
Knowledge-based reduction of cancer-speciﬁc networks
In order to address these issues, we devised a knowledge-based
graph reduction procedure by edge contraction, which is a
Published in partnership with the Systems Biology Institute
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fundamental operation in graph theory17. Here, the idea is to
remove a particular edge and then merge the incident nodes of
that edge to form a new node. Edge contraction is widely used in
recursive formulas to calculate the number of spanning trees of an
arbitrary connected graph18, and in recurrence formulas to
calculate the chromatic polynomial of a simple graph19. Nonetheless, a simple edge contraction based solely on the connectivity is not going to produce the desired outcome in our case
because we also need to account for the features of nodes.
Therefore, we developed a knowledge-based edge contraction
algorithm employing both connectivity and biological feature
information to satisfy the following conditions: both incident
nodes need to be non-kinase proteins, share the same differential
gene expression, and belong to the same biological process
cluster. The last condition is very important to ensure that the
reduction merges only those nodes belonging to the same
pathway, thus supporting the biological knowledge. Biological
processes in cancer-speciﬁc networks are determined by clustering nodes according to the similarity of their Gene Ontology
(GO) terms.
GOGO is a method to calculate semantic similarities between
GO terms using Directed Acyclic Graphs (DAGs)20. GO consists of
three DAGs created based on molecular function (MF), cellular
component (CC), and biological process (BP) ontologies21. In order
to verify that the network locality is preserved when using GOGO
similarities derived from the BP ontology, we ﬁrst calculated
similarity values between 1st, 2nd, 3rd, and 4th order neighbors in
the full-size PPI network. Figure 2 shows that GOGO similarities are
the highest for the 1st order neighbors and decrease with the
increasing order. These results corroborate previous studies
demonstrating that the closer the two proteins are in the network
the more similar are their biological functions22. Next, using GOGO
similarities and the hierarchical clustering analysis (HCA), all
proteins in the graph were partitioned into 30 (HCA-30), 100
(HCA-100), and 300 (HCA-300) clusters. Only those nodes
belonging to the same cluster are allowed to be merged during
graph reduction.

Fig. 2 Histogram of the pairwise GOGO similarity scores across
the protein-protein interaction network. GOGO similarities are
calculated using the biological process ontology for 1st, 2nd, 3rd,
and 4th order neighbors in the network.
Published in partnership with the Systems Biology Institute

The reduction procedure for a graph is schematically shown in
Fig. 3. An edge may be contracted only if both incident nodes are
non-kinases, share the same differential gene expression, and
belong to the same GOGO cluster. Yellow squares in Fig. 3A
delineate groups of nodes that can be merged by contracting
edges connecting them. The resulting reduced graph shown in
Fig. 3B has the same number of kinases (circles), but fewer nonkinase proteins (rounded squares and diamonds representing
merged nodes). The rationale behind this procedure is not only to
reduce the size of a graph, but also to create more diversity
among cell lines, which is highly beneﬁcial for further machinelearning applications. Note that the reduction is performed on
different cell lines without any drug information because we
consider only the differential gene expression, the type of node
(kinase or non-kinase protein), and the biological process assignment of nodes, with the latter two properties being independent
on the cell line type.
Analysis of full-size and reduced networks
Compared to the original PPI network (Fig. 3C), the reduced graph
(Fig. 3D) has a much higher ratio of kinase (red dots) to non-kinase
(green dots) proteins. Table 1 shows that after the reduction, the
number of nodes decreased from 19,144 to 1349 and the graph
density increased from 0.004 to 0.014, saving computational
resources in future graph processing. Further, a higher clustering
coefﬁcient for reduced graphs implies that they have better
structures in terms of the information exchange than full-size
networks. A high maximum betweenness centrality is to be
expected since reduced graphs contain a super-hub node
connected to many other nodes in the graph. A signiﬁcant
increase of the average betweenness centrality indicates that the
information is going to ﬂow more efﬁciently throughout reduced
graphs. Overall, statistics reported in Table 1 demonstrate that in
contrast to full-size networks, reduced graphs are compact, yet
information-rich offering an effective representation of the
biological data for machine-learning applications.
The graph reduction procedure greatly increases the diversity of
graph topologies and features across all 359 cancer cell lines,
while maintaining the important information and biological
knowledge in each graph. In order to demonstrate the effectiveness of our reduction scheme, we calculated the information gain/
loss after the reduction using the Shannon entropy of features and
the graph-feature entropy (see Eq. 3). Ideally, the graph reduction
should increase the information content for features without any
decrease in the graph-feature information. The information gain/
loss is shown in Fig. 4 for several reduction schemes. Although the
simplest reduction requiring incident nodes to share at least one
GO-BP term increases the feature-only entropy by 2.3 ± 0.6 (green
bar), it causes a detrimental decrease of the graph-feature entropy
by −0.4 ± 0.04 (red bar). In contrast, HCA increases the feature-only
entropy while preserving the valuable graph-feature information.
In particular, partitioning nodes into 30 clusters not only yields the
highest information gain for features of 3.5 ± 0.9, but also slightly
increases the graph-feature entropy. Based on these results and
due to the fact that there are actually 30 level-1 biological
processes in GO23, we incorporated HCA-30 into the graph
reduction procedure.
Comparison of matrix- and graph-based machine-learning
approaches
In order to properly evaluate the performance of methods to
predict the response of cancer to drugs, we conducted a crossvalidation at the tissue level. The entire dataset was ﬁrst divided
into nine groups of different tissues, digestive system, respiratory
system, haematopoietic and lymphoid tissue, breast tissue, female
reproductive system, skin, nervous system, excretory system, and
others. Next, we conducted a 9-fold cross-validation, each time
npj Systems Biology and Applications (2022) 14
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Fig. 3 Graph reduction of cancer-speciﬁc networks. A A schematic of the initial graph with yellow boxes outlining groups of nodes that can
be merged by contracting their edges. B A schematic graph of the reduced graph in which merged nodes are represented by diamonds.
C The initial (sub)network for glioblastoma (cell line A172) with red nodes representing kinases and green nodes representing other proteins.
D The reduced network for glioblastoma colored the same as in (C). The network in (C) is a randomly sampled subgraph from the original
network with the same number of nodes as (D).

using cancer cell lines from one tissue as a validation set while the
remaining cancer cell lines were used for model training. Since cell
lines collected from different tissues have different gene expression patterns, this cross-validation scheme eliminates the overlap
between training and validation data. In addition, there is also a
desired feature variability on account of different gene-disease
associations which depend on the cell line and tissue type.
Essentially, each fold has entirely different training and validation
data.
Table 2 reports the cross-validated performance of matrix- and
graph-based algorithms. The ﬁrst matrix-based approach employs
a multilayer perceptron (MLP) to the differential gene expression
data along with ligand embeddings. This method represents an
appropriate baseline because many available tools reported in the
literature utilize similar data frameworks24. The cross-validated
accuracy of the baseline algorithm is only 0.55 indicating that the
model is unable to discover the underlying patterns connecting
npj Systems Biology and Applications (2022) 14

the genomic data and small molecule descriptors. We also tested
another matrix-based approach utilizing the same set of features
as that used in the graph-based model. The accuracy of this
classiﬁer indeed improved to 0.60 demonstrating that kinase
inhibitor proﬁling and disease-gene associations are more
effective compared to ligand embeddings. One possible reason
for this improved accuracy is that chemically dissimilar drugs can
exhibit similar pharmacological effects in cell lines sensitive to
these compounds25, which remains undetected by using ligand
embeddings.
In addition to MLP, we tested two other machine-learning
approaches, Support Vector Machines (SVM) and Random Forest
(RF), both employing the Principal Component Analysis (PCA) to
reduce the dimensionality of input feature vectors. Although
using SVM-PCA yields a higher accuracy than MLP, the Matthews
correlation coefﬁcient26 and F-score values are notably lower.
These results demonstrate that MLP achieves a robust
Published in partnership with the Systems Biology Institute
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Table 1.

Properties of full-size and reduced graphs.

Property

Full- size graph

Reduced graphs

Number of nodes

19,144

1349 ± 80

Number of edges

685,198

Table 2. Performance of algorithms to predict the response of cancer
cell lines to drugs.
Data type Model

Features

ACC PPV TPR MCC F-score

12,613 ± 608

Matrix

MLP

DGE, LE

0.55 0.63 0.64 0.27

0.55

MLP

DGE, KIP, DGA 0.60 0.60 0.60 0.20

0.60
0.40
0.45

Average degree

71

19 ± 0.3

Matrix

Density

0.004

0.014 ± 0.0009

Matrix
Matrix

SVM-PCA DGE, LE
0.61 0.70 0.51 0.10
SVM-PCA DGE, KIP, DGA 0.62 0.72 0.53 0.16

Matrix

RF-PCA

DGE, LE

0.42 0.56 0.52 0.06

0.33

Matrix

RF-PCA

DGE, KIP, DGA 0.44 0.56 0.53 0.09

0.39

Graph

WL Tree

DGE, KIP, DGA 0.68 0.67 0.65 0.32

0.65

Diameter

8

4.073 ± 0.26

Clustering coefﬁcient
Maximum betweenness
centrality
Average betweenness
centrality

0.287
0.021

0.659 ± 0.006
0.596 ± 0.011

1.11 × 10−4

7.88 × 10−4 ± 4.49 × 10−6

Statistics are calculated from the graph topology without considering node
features. Values for reduced graphs are reported as the average ±standard
deviation across the dataset.

Fig. 4 Entropy gain/loss for different reduction schemes. Purple
bars represent the Shannon entropy calculated using the feature
matrix only, while yellow bars correspond to the graph-feature
entropy computed using both feature and topological information
of a graph. GO-BP requires that two incident nodes have a common
biological process term to be assigned to the same cluster. HCA bars
correspond to the clustering using GOGO similarities into 30, 100,
and 300 clusters.

performance across four confusion matrix categories (true
positives, false negatives, true negatives, and false positives),
proportionally to the size of positive and negative instances27. It is
noteworthy that similar to MLP, SVM-PCA and RF-PCA perform
better when kinase inhibitor proﬁling and disease-gene associations are used instead of ligand embeddings. Encouragingly, a
graph-based approach employing the WL Tree, a widely adopted
graph kernel method for graph machine learning10, yields the
highest classiﬁcation accuracy of 0.68, the MCC of 0.32, and the
F-score of 0.65, outperforming all matrix-based algorithms. These
benchmarking calculations demonstrate that the non-Euclidean
representation offers a powerful approach to fully utilize
biological data in machine learning.
DISCUSSION
In this communication, we describe a new procedure to construct
cancer-speciﬁc biological networks by integrating multiple heterogeneous data, including protein-protein interactions, differential
Published in partnership with the Systems Biology Institute

A graph-based approach is compared to two matrix-based methods. The
performance of each algorithm is cross-validated at the tissue level.
MLP multilayer perceptron, SVM-PCA Support Vector Machines with
Principal Component Analysis, RF-PCA Random Forest with Principal
Component Analysis, WL Tree Weisfeiler–Lehman graph kernel, DGE
differential gene expression, LE ligand embeddings, KIP kinase inhibitor
proﬁling, DGA disease-gene associations, ACC accuracy, PPV precision, TPR
recall, MCC Matthews correlation coefﬁcient.

gene expression, gene-disease associations, and kinase inhibitor
proﬁling. In order to improve the effectiveness of machine
learning, a graph reduction protocol was implemented to convert
initially information-sparse biological networks to information-rich
graphs preserving the biological knowledge. In contrast to the
original PPI networks that share exactly the same topology, the
reduced graphs provide a diverse set of graph topologies across
different cell lines. In addition, because of the much smaller size
compared to full-size PPI networks, the reduced graphs can be
used with any machine-learning model, even those that are
computationally expensive. Overall, our procedure to construct
cancer-speciﬁc molecular networks enables a more efﬁcient
learning process on account of the more diverse and
information-rich data. This approach improves the performance
of machine learning to predict the responsiveness of cancer to
pharmacotherapy.
MATERIALS AND METHODS
Protein-protein interaction network
Protein-protein interaction data were acquired from the STRING database28
that comprises 19,354 human proteins forming 11,355,804 interactions
including those identiﬁed experimentally and predicted computationally.
Each interaction is assigned a conﬁdence score ranging from 150 for lowconﬁdence to 999 for high-conﬁdence interactions. A human PPI network
was constructed from conﬁdent interactions with a score of ≥500. Single
proteins disconnected from the main network and those forming small,
isolated networks were removed, resulting in the ﬁnal PPI network
containing 19,144 proteins and 685,198 interactions.

Differential gene expression data
Original gene expression data are available from the Cancer Cell Line
Encyclopedia (CCLE) project comprising a detailed genetic characterization
of a large number of cancer cell lines29. We obtained the curated CCLE data
from Harmonizome, a comprehensive repository of processed genomics,
proteomics, epigenomics, transcriptomics, and metabolomics data30. The
differential gene expression (DGE) data contain 18,022 genes, 1035 cancer
cell lines, and 749,551 gene-cell associations categorized as down-, up-,
and normally regulated with respect to the expression level in
healthy cells.

Kinase inhibitor proﬁling
Inhibitor proﬁling refers to a large-scale experimental measurement of the
activity of an inhibitor against a panel of target proteins. The kinase
npj Systems Biology and Applications (2022) 14
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inhibitor proﬁling (KIP) data used in this study were collected and curated
by Team-SKI31. The activity is reported as a pIC50 value, which is the
negative logarithm of the half-maximal inhibitory concentration (IC50)
measuring the potency of a compound in inhibiting a speciﬁc biochemical
function. The cutoff for pIC50 values was set at 6.3 corresponding to the
IC50 of 500 nM. The Team-SKI dataset contains 49,348 small molecules
tested against 411 protein kinases.

Disease-gene associations
Disease-gene association (DGA) scores were obtained from two sources,
DISEASES32 and DisGeNET33. The DISEASES database integrates evidence
on associations collected through automatic text mining, manually curated
from biomedical literature, cancer mutation data, and genome-wide
association studies. It contains 8330 diseases and 20,715 genes with
association scores ranging from 1 to 10. The DisGeNET database provides
information on associations pulled from various repositories including
Mendelian, complex and environmental diseases, and integrated using
gene/disease vocabulary mapping and the DisGeNET ontology. It
comprises 24,166 diseases and 17,545 genes with association scores
ranging from 0.01 to 1.

Data integration
Data integration was performed by mapping DGE, KIP, and DGA values
directly onto the PPI network. Gene expression data contains normalized
scores for 18,022 genes, whereas the PPI network comprises 19,144
proteins. The missing values for nodes in the graph were replaced by
median scores calculated over 1st order neighbors. The kinase component
of the PPI network was determined by running Basic Local Alignment
Search Tool (BLAST)34 against known human kinases35. Using a similarity
threshold of 95% identiﬁed 508 kinases. pIC50 values are available from the
Team-SKI database for 411 kinase proteins in our network and 29 small
molecules that are also present in the growth rate inhibition data from
LINCS. The Disease Ontology ID (DOID) and the Concept ID for each cancer
cell line were identiﬁed with the Cellosaurus resource portal36, and
mapped to, respectively, DISEASES and DisGeNET databases in order to
assign disease-gene association scores to nodes in the PPI network. After
integrating all data and removing cases that could not be mapped, the
ﬁnal dataset contains annotated graphs for 3,549 combinations of 359 cell
lines and 29 drugs.

Growth rate inhibition data
Proliferation is measured by GR50 and GRmax indices quantifying the
value of growth rate inhibition (GR) based on time course and endpoint
assays37. GR50 is the concentration of a drug at which GR is 0.5, whereas
GRmax is the maximum measured GR value. In this study, we employ
GRmax values for the following dose-response datasets: Broad-HMS
LINCS Joint Project, LINCS MCF10A Common Project, HMS LINCS
Seeding Density Project, MEP-HMS LINCS Joint Project, Genentech Cell
Line Screening Initiative, and Cancer Therapeutics Response Portal37.
The benchmarking dataset comprises 2124 positive instances of cell
line-drug combinations with negative GRmax values signifying a
cytotoxic response, and 1425 negative instances with positive GRmax
values signifying a cytostatic response.

Graph partitioning
The latest release of the GO database contains 29,698 BP, 11,147 MF,
and 4201 CC ontology terms21. Each DAG has its own hierarchy
maintained by the domain-centric Gene Ontology (dcGO). According to
the dcGO database, the numbers of level-1 nodes are 30, 15, and 22 for
BP, MF, and CC, respectively23. Since our goal was to assign nodes to
biological pathways, all-against-all semantic similarities between GO
terms of PPI network nodes were calculated with the GOGO software
based on the BP-DAG topology. The matrix of GOGO scores was then
subjected to a hierarchical clustering analysis, which builds nested
clusters by successively merging and splitting clusters38. There are two
types of hierarchical clustering, agglomerative (bottom-up) and divisive
(top-down). Agglomerative methods merge observations as moving up
the hierarchy while divisive methods split the observations as moving
down the hierarchy. Here, we employed the agglomerative HCA rather
than other commonly used clustering methods, such as k-means39,
DBSCAN40, and afﬁnity propagation41 because this technique is the
most appropriate for GOGO semantic similarities and we found
npj Systems Biology and Applications (2022) 14

empirically that the clustering results represent well different levels of
biological process in GO.

Graph statistics
Average degree of a graph is calculated by averaging
nodes, deﬁned as the mean number of connections
the graph.
Density, ρG , is deﬁned as the ratio of the number
number of possible edges. For an undirected graph, it
ρG ¼

the degrees of all
to other nodes in
of edges and the
is calculated as

2 jE j
jV jðjV j  1Þ

(1)

where jEj is the number of edges and jVj is the number of nodes. Since the
information is propagated more efﬁciently across dense graphs, increasing
the graph density is generally beneﬁcial for graph learning algorithms,
such as GNN.
Diameter is the longest shortest path between any two nodes in a
graph19, i.e. the longest distance one must traverse from one node to
reach another node. This is an important property because it directly
informs the design of a graph model.
Clustering coefﬁcient measures the tendency of nodes to form clusters.
Most real-world graphs, such as social, powerline, citation, language, food,
economic, and biological networks, tend to form communities, which are
characterized by a high density of ties42. The higher the clustering
coefﬁcient, the more likely nodes are to form communities resulting in a
shift of the information exchange from global to local.
Betweenness centrality of a node is the sum of the fraction of all-pair
shortest paths passing the node43. Essentially, this property evaluates the
amount of information ﬂowing through nodes, i.e., a high betweenness
centrality signiﬁes more information ﬂowing through a graph. Further,
those nodes with a high information ﬂow interact more frequently with
other nodes, maintaining a signiﬁcant control over the entire network.

Graph-feature entropy
A graph reduction basically compresses the information in a graph.
However, as all lossy compression schemes, some information will be lost
during the reduction. In order to measure how much meaningful
information is lost or gained as opposed to the loss/gain of the redundant
or irrelevant information, we introduce a concept of the graph-feature
entropy. Brieﬂy, the graph-feature entropy S of a graph G, SG , is based on
the Shannon entropy40 deﬁned as:
X  
 
p zj log p zj
SG def 
(2)
j

where zj is the column vector of the feature matrix ﬁltered by the graph
Laplacian, which corresponds to the j-th feature of all nodes in the graph.
Using features ﬁltered with the graph Laplacian effectively combines both
feature and topological information of a graph providing a useful measure
of the information content in featured graphs.
Next, we calculate the information gain/loss after the reduction, δ, using
the Shannon entropy of features and the graph-feature-entropy:
δ¼

Sreduced  Soriginal
Soriginal

(3)

where Soriginal is the entropy (either feature-only or graph-feature) of the
original graph and Sreduced is the corresponding entropy of the
reduced graph.

Matrix-based methods to predict drug response
The rows of input matrices are gene products, and the columns contain
various features. The baseline matrix includes only the DGE data, and
after ﬂattening to a 19,144-element vector, it is concatenated to a 300element vector of ligand embeddings (LE) computed by Mol2vec41 for
the input drug. The baseline classiﬁer utilizing 19,444-element input
feature vectors represents an archetypal approach to predict a drug
response based solely on the gene expression changes and the drug
chemical structure. The second method utilizes a full input matrix of
19,144 gene products × 3 features, DGE, KIP, and DGA, ﬂattened to a
57,432-element vector. This approach is a matrix-based equivalent of
the graph-based method utilizing exactly the same input features. Both
matrix-based classiﬁers employ an MLP with an input layer of either
19,444 units for the baseline or 57,432 units for the graph-equivalent
Published in partnership with the Systems Biology Institute
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method, three hidden layers comprising 1024, 512, and 256 units, and a
2-unit output layer returning probabilities for the input drug to be
effective and ineffective against the cell line.

Graph-based method to predict drug response
The graph-based approach devised in this study employs the WL graph
kernel, also known as WL Tree classiﬁer10, to the reduced representations
of cancer-speciﬁc PPI networks comprising DGE, KIP, and DGA data. WL
Tree is a widely adopted method for learning from graphs with discrete
node labels. A key component of this algorithm is a rapid feature
extraction employing the WL test of isomorphism on graphs. Brieﬂy, WL
Tree iteratively maps the original node labels to new node labels based on
the topological structure of the graph. The new node labels are then
compressed and integrated with the original node labels in order to form a
vector representation for the graph. The implementation of WL Tree used
in this study was previously demonstrated to outperform other graph
kernels on several graph classiﬁcation benchmark datasets in terms of
accuracy and runtime.

DATA AVAILABILITY
Data generated in this study are freely available to the academic community at
https://osf.io/dzx7b/.
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